Source: Υπουργείο Υγείας (CY) Revision Year: 2007 Publisher: George Petrou Ltd., 50, Areos Str, Latsia 2234, Nicosia, Cyprus
Beclazone 100 micrograms CFC Free Inhaler Pressurised Inhalation Solution.
| Pharmaceutical Form |
|---|
|
Pressurised Inhalation, Solution. Pressurised container fitted with a metering valve and an actuator. The colour of the actuator is brown with a beige dust cap. |
One metered dose contains 100 micrograms Beclometasone Dipropionate Anhydrous.
For a full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Beclometasone |
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
| List of Excipients |
|---|
|
Ethanol anhydrous 99.5% |
Pressurised container fitted with a metering valve.
The can is of 19ml nominal capacity manufactured from aluminium with either a debossed or a plain base. The can opening is configured to accept 20mm valves. Each pack contains a single inhaler which supplies a minimum of 200 actuations.
George Petrou Ltd., 50, Areos Str, Latsia 2234, Nicosia, Cyprus
14683
14th November 1997 / 14th November 2002
| Drug | Countries | |
|---|---|---|
| BECLAZONE | Cyprus, Estonia, Hong Kong, Ireland, New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
